Masimo (MASI) Competitors

$136.95
+2.63 (+1.96%)
(As of 04/23/2024 ET)

MASI vs. ITGR, TMDX, LIVN, CNMD, BRBR, CYTK, VKTX, CERE, GMED, and EXEL

Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), TransMedics Group (TMDX), LivaNova (LIVN), CONMED (CNMD), BellRing Brands (BRBR), Cytokinetics (CYTK), Viking Therapeutics (VKTX), Cerevel Therapeutics (CERE), Globus Medical (GMED), and Exelixis (EXEL). These companies are all part of the "medical" sector.

Masimo vs.

Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, community ranking, analyst recommendations, dividends, media sentiment and earnings.

Integer currently has a consensus target price of $120.50, suggesting a potential upside of 2.75%. Masimo has a consensus target price of $137.43, suggesting a potential upside of 0.66%. Given Masimo's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Masimo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Integer has higher earnings, but lower revenue than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.48$90.65M$2.6943.92
Masimo$2.05B3.54$81.50M$1.5190.68

Integer has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.

Integer has a net margin of 5.68% compared to Integer's net margin of 3.98%. Integer's return on equity of 13.77% beat Masimo's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer5.68% 10.80% 5.48%
Masimo 3.98%13.77%5.98%

In the previous week, Integer had 4 more articles in the media than Masimo. MarketBeat recorded 16 mentions for Integer and 12 mentions for Masimo. Integer's average media sentiment score of 0.65 beat Masimo's score of 0.34 indicating that Masimo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Masimo
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Masimo received 79 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.02% of users gave Masimo an outperform vote while only 63.33% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
373
63.33%
Underperform Votes
216
36.67%
MasimoOutperform Votes
452
64.02%
Underperform Votes
254
35.98%

99.3% of Integer shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 9.7% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Integer and Masimo tied by winning 9 of the 18 factors compared between the two stocks.

Get Masimo News Delivered to You Automatically

Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MASI vs. The Competition

MetricMasimoElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$7.24B$3.04B$4.80B$7.47B
Dividend YieldN/A1.82%5.47%3.97%
P/E Ratio90.6811.39188.7016.65
Price / Sales3.5465.962,570.7482.50
Price / Cash23.3850.3031.6927.23
Price / Book5.313.784.664.30
Net Income$81.50M$87.48M$101.62M$213.07M
7 Day Performance-0.91%0.47%-0.21%0.67%
1 Month Performance1.47%5.19%-5.70%-4.11%
1 Year Performance-30.15%0.11%9.61%6.09%

Masimo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.4441 of 5 stars
$119.31
+0.6%
$120.50
+1.0%
+41.7%$4.00B$1.60B44.3510,500Upcoming Earnings
Analyst Revision
High Trading Volume
TMDX
TransMedics Group
0.8006 of 5 stars
$93.31
+1.6%
$102.00
+9.3%
-2.5%$3.05B$241.62M-121.18584Upcoming Earnings
LIVN
LivaNova
1.4106 of 5 stars
$53.18
-0.4%
$64.40
+21.1%
+8.4%$2.87B$1.15B166.192,900
CNMD
CONMED
4.8207 of 5 stars
$77.48
+3.0%
$120.43
+55.4%
-37.5%$2.39B$1.24B37.984,000Upcoming Earnings
News Coverage
BRBR
BellRing Brands
3.2615 of 5 stars
$55.21
+1.3%
$57.08
+3.4%
+53.8%$7.23B$1.67B44.52420Analyst Report
News Coverage
Positive News
CYTK
Cytokinetics
3.9049 of 5 stars
$69.00
+1.5%
$79.33
+15.0%
+72.9%$7.22B$7.53M-12.66423
VKTX
Viking Therapeutics
4.7478 of 5 stars
$67.95
+1.5%
$112.25
+65.2%
+201.0%$7.49BN/A-73.8627Upcoming Earnings
CERE
Cerevel Therapeutics
0.2157 of 5 stars
$41.31
-0.9%
$41.40
+0.2%
+55.2%$7.50BN/A-16.52334
GMED
Globus Medical
4.7719 of 5 stars
$51.79
-0.1%
$66.33
+28.1%
-11.5%$7.01B$1.02B44.275,000
EXEL
Exelixis
4.99 of 5 stars
$22.82
+0.5%
$26.29
+15.2%
+20.3%$6.92B$1.83B35.661,310Upcoming Earnings

Related Companies and Tools

This page (NASDAQ:MASI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners